Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Holders of 5% or more of TCON
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tracon Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Tracon Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Tracon Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 27, 2022 | Linden Capital L.P. | 13G/AOld format | – | – | – | SEC |
| Mar 11, 2021 | New Enterprise Associates 14, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | 683 Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Opaleye Management Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Linden Capital L.P. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Tracon Pharmaceuticals, Inc. shares.
No Form 144 notices for Tracon Pharmaceuticals, Inc. are on file.